logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
ScreenersScreeners
MoreMore
prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
EMA ScreenerEMA Screener
SMA ScreenerSMA Screener
WMA ScreenerWMA Screener
OHLC ScreenerOHLC Screener
Fibonacci ScreenerFibonacci Screener
VWAP ScreenerVWAP Screener
Pivot Point ScreenerPivot Point Screener
Overlay ScreenerOverlay Screener
Trend Indicator ScreenerTrend Indicator Screener
Volume Based Indicator ScreenerVolume Based Indicator Screener
Overbought/Sold ScreenerOverbought/Sold Screener
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Precious Metals
Gold Price TodayGold Price TodayNew
Silver Price TodaySilver Price TodayNew
Platinum Price TodayPlatinum Price TodayNew
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Procter & Gamble Health Ltd

Procter & Gamble Health

Mid Cap•1,336 Employees•IPO 1993
Current Price
₹6056.00
-191.5 (-3.07%)Updated
NSE :PGHL
BSE :500126
Sector :Pharmaceuticals
Today's Range
5953
₹6056.00
indicator
6389
52 Week Range
52W Low₹4707.00
52W High₹6739.00
₹6056.00
indicator
Downside28.66%
Upside11.28%
chart iconChart

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
₹8,435.81 Cr
Market Cap
Total market value of company
P/E Ratio
27.50
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
16.89
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
₹184.66
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
40.85%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
47.80%
ROCE
Return on Capital Employed. >15% is good
Net Margin
23.89%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
-1.16%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
-7.18%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
19.30%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
158.00%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.01
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
₹323.48
Book Value
Net asset value per share
Dividend Yield
3.64%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
51.80%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

5 points
  • •Exceptional capital utilization with ROE 36.4% and ROCE 47.8%.
  • •Impressive 158% quarterly profit growth signals strong market demand.

Weaknesses

5 points
  • •High P/E ratio of 34.20 suggests potential overvaluation versus peers.
  • •Historical quarterly net profit volatility indicates susceptibility to market shifts.

Opportunities

5 points
  • •Increasing global healthcare expenditure and aging population drive demand.
  • •Expand product portfolio and penetrate emerging markets leveraging brand.

Threats

4 points
  • •Intense competition from major players pressures market share and margins.
  • •Evolving strict regulatory policies, including drug pricing controls, impact profitability.

Segment-wise Financial Analysis

Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

No insider trading data available

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4₹7184.33+₹1128.33+18.63%
R3₹6748.33+₹692.33+11.43%
R2₹6568.67+₹512.67+8.47%
R1₹6312.33+₹256.33+4.23%
PIVOT₹6132.6776.671.27%
CURRENT₹6056.00--
S1₹5004.33-₹1051.67-17.37%
S2₹5440.33-₹615.67-10.17%
S3₹5696.67-₹359.33-5.93%
S4₹5876.33-₹179.67-2.97%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
0.69L
(29 May 2026)
+57.5% vs avg
Delivery %
44.5%
(29 May 2026)
-11.8% vs avg
Avg Volume (20D)
0.44L
(30 Apr - 29 May)
20-day average
Avg Delivery %
56.3%
(30 Apr - 29 May)
Trend ↓
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Sun Pharmaceutical Industries Ltd
4.12L ₹ Cr
Best Profit Growth
Shilpa Medicare Ltd
234.00 %
Highest Dividend Yield
Sanofi India Ltd
2.91 %

Peer Comparison

Company Name
AARTIPHARM
Aarti Pharmalabs Ltd
AETHER
Aether Industries Ltd
ALIVUS
Alivus Life Sciences Ltd
BLUEJET
Blue Jet Healthcare Ltd
FDC
FDC Ltd
GRANULES
Granules India Ltd
MARKSANS
Marksans Pharma Ltd
RUBICON
SANOFI
Sanofi India Ltd
SANOFICONR
Sanofi Consumer Healthcare India Ltd
SHILPAMED
Shilpa Medicare Ltd
STAR
Strides Pharma Science Ltd
SUNPHARMA
Sun Pharmaceutical Industries Ltd

About

PGHL

Procter & Gamble Health Ltd

Procter & Gamble Health Limited (PGHL) is a prominent player in the Indian pharmaceutical and consumer healthcare market, with an established international presence. Its core business revolves around the manufacturing and marketing of a diverse range of health-related products.

The company's product portfolio is primarily focused on over-the-counter (OTC) medications, vitamins, minerals, and dietary supplements. This caters to a broad consumer base seeking self-care solutions for various health needs. These products are marketed under several well-recognized brand names, including Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas. Each brand likely targets specific segments within the healthcare market, offering specialized products to meet differing consumer demands.

PGHL's history traces back to 1967, originally operating under the name Merck Limited. The company underwent a significant rebranding in May 2019, adopting its current name to reflect its ownership under the Procter & Gamble umbrella. This change underscores the strategic alignment with the larger global Procter & Gamble corporation, leveraging its extensive resources and brand recognition for expansion and growth within the Indian and international markets.

The company's headquarters are located in Mumbai, India, strategically positioning it within a large and rapidly growing consumer market. Its status as a subsidiary of Procter & Gamble Overseas India BV further highlights its integration within the larger Procter & Gamble global network. This structure likely provides access to significant resources, technological advancements, and distribution channels, enhancing the company's competitiveness and market reach.

In summary, PGHL's business model centers on the development, production, and marketing of a diverse range of healthcare products targeting various consumer needs. Its strong brand portfolio, backed by the resources of Procter & Gamble, positions it for continued growth and success within the competitive healthcare landscape.

COMPANY FACTS - PGHL

Registered Address

P & G Plaza, Cardinal Gracias Road Chakala, Andheri East, Mumbai City

Mumbai

MAHARASHTRA

IN

Tel: 912262109000

Website:https://www.pghealthindia.com/

Investor Relations:http://www.pghealthindia.com/investors/
Company Details

Group: Pharmaceuticals, Biotechnology & Life Sciences

Sector: Health Care

Industry: Pharmaceuticals

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 1,336

IPO Date: 21/11/1993

MANAGEMENT - PGHL

Mr. Suresh Talwar

Non-Executive Independent Chairman of the Board

Mr. Lokesh Chandak

Chief Financial Officer, Executive Director

Ms. Zeal Rupani

Compliance Officer, Company Secretary

Mr. Milind Thatte

Managing Director, Executive Director

Mr. Aalok Agrawal

Non-Executive Director

Ms. Seema Sambasivan

Non-Executive Director

Mrs. Rani Jadhav

Non-Executive Independent Director

Mr. Subramanian Madhavan

Non-Executive Independent Director

Investor Questions Answered

Procter & Gamble Health Ltd (PGHL) Stock FAQs

Get answers to the most common questions about Procter & Gamble Health Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of Procter & Gamble Health Ltd (PGHL) is ₹6,056. Today, the stock has declined by ₹191.50 (3.07%), trading in a range of ₹5,953 to ₹6,389. The stock opened at ₹6,076 with a trading volume of 68,807 shares.
Procter & Gamble Health Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹8,435.81 crores, P/E ratio of 27.50, ROE of 40.85%, and ROCE of 47.80%. The dividend yield stands at 3.64%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Procter & Gamble Health Ltd (PGHL) is ₹6,739, while the 52-week low is ₹4,707. Currently trading at ₹6,056, the stock is 66.4% away from its 52-week low and 10.1% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Procter & Gamble Health Ltd stock at ₹6,056 depends on multiple factors. The stock is currently trading with a P/E ratio of 27.50 and P/B ratio of N/A. Today's performance shows a loss of 3.07%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Procter & Gamble Health Ltd offers a dividend yield of 3.64%, which means for every ₹100 invested at the current price of ₹6,056, you can expect to receive approximately ₹3.64 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Procter & Gamble Health Ltd's key financial metrics include: P/E Ratio: 27.50, P/B Ratio: N/A, ROE: 40.85%, ROCE: 47.80%, Dividend Yield: 3.64%, EPS: ₹184.66, Book Value: ₹323.48, Debt-to-Equity: 0.01, and Current Ratio: N/A. The company's market cap stands at ₹8,435.81 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Procter & Gamble Health Ltd stock opened at ₹6,076 and is currently trading at ₹6,056, showing a decline of ₹191.50 (3.07%). The intraday high is ₹6,389 and low is ₹5,953. The trading volume stands at 68,807 shares, indicating moderate market participation today.
Procter & Gamble Health Ltd has a Price-to-Earnings (P/E) ratio of 27.50, which means investors are willing to pay ₹27.50 for every ₹1 of earnings. With an EPS of ₹184.66, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Procter & Gamble Health Ltd has a market capitalization of ₹8,435.81 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹6,056) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Procter & Gamble Health Ltd has a book value of ₹323.48 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹6,056, which is 1772.1% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Procter & Gamble Health Ltd has a Return on Equity (ROE) of 40.85% and Return on Capital Employed (ROCE) of 47.80%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. Both metrics are strong, indicating efficient capital utilization. Higher percentages generally indicate better financial performance.
Procter & Gamble Health Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Procter & Gamble Health Ltd has a debt-to-equity ratio of 0.01, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Procter & Gamble Health Ltd has an Earnings Per Share (EPS) of ₹184.66, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹6,056 and P/E ratio of 27.50, investors are paying 27.50 times the annual earnings per share. This strong EPS indicates robust profitability. Track EPS growth over quarters to assess earnings momentum.
Procter & Gamble Health Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Procter & Gamble Health Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Procter & Gamble Health Ltd stock, consider: 1) Fundamental Analysis - Review P/E (27.50), ROE (40.85%), debt-to-equity (0.01), and growth rates. 2) Technical Analysis - Check 52-week range (₹4707.00 - ₹6739.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹6056.00) with book value (₹323.48) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Procter & Gamble Health Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹6,056 is 60460x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Procter & Gamble Health Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹4707.00 - ₹6739.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.01 indicates leverage. 4) Liquidity Risk - Based on trading volume of 68,807 shares. 5) Valuation Risk - P/E of 27.50 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Procter & Gamble Health Ltd operates in the industry with key metrics: P/E ratio of 27.50, ROE of 40.85%, market cap of ₹8,435.81 crores, and dividend yield of 3.64%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.01), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Procter & Gamble Health Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹6,056, with a 52-week range of ₹4707.00 to ₹6739.00. Based on fundamentals like P/E (27.50), ROE (40.85%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Procter & Gamble Health Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹6056.00. 2) Fundamental Deterioration - Declining ROE (currently 40.85%), increasing debt (D/E: 0.01), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Procter & Gamble Health Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 3.64%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.

Related

Peers, sector trends, screeners and strategy playbooks contextual to this stock.